Skip to main content
. 2016 Feb 15;43(8):869–880. doi: 10.1111/1346-8138.13258

Figure 5.

Figure 5

Change from baseline in laboratory parameters through follow‐up, for (a) neutrophil counts, (b) lymphocyte counts, (c) hemoglobin levels, (d) creatine phosphokinase, (e) LDL cholesterol, (f) HDL cholesterol and (g) LDL/HDL ratio, by initially randomized dose group (safety analysis set). HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; SD, standard deviation.